The interaction mode of premalignant Schwann and immune effector cells during chemically induced carcinogenesis in the rat peripheral nervous system is strongly influenced by genetic background

Cancer Research

Volumn 66, Issue 9, 2006, Pages 4708-4714

  Gering, Katharina M ^a   Marx, Judith A M ^b   Lennartz, Klaus ^a   Fischer, Christine ^c   Rajewsky, Manfred F ^a   Kindler Röhrborn, Andrea ^b  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ETHYLNITROSOUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; EFFECTOR CELL; GENETIC TRAIT; HELPER CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PERINATAL PERIOD; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SCHWANN CELL; TRIGEMINAL NERVE; TUMOR RESISTANCE;

ANIMALS; ANTIBODIES; ANTIGENS, CD18; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CRANIAL NERVE NEOPLASMS; ETHYLNITROSOUREA; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MACROPHAGES; NEURILEMMOMA; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED STRAINS; SCHWANN CELLS; T-LYMPHOCYTES, CYTOTOXIC; TRIGEMINAL NERVE;

EID: 33646430301     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3780     Document Type: Article

References (27)

1. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003;33 Suppl:238-44.
2. Balmain A, Nagase H. Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet 1998;14:139-44.
3. Druckrey H. Genotypes and phenotypes of ten inbred strains of BD-rats. Arzneimittelforschung 1971;21:1274-8.
4. Druckrey H, Landschutz C, Ivankovic S. [Transplacental induction of malignant tumours of the nervous system. II. Ethyl-nitrosurea in 10 genetically defined strains of rats]. Z Krebsforsch 1970;73:371-86.
5. Kindler-Rohrborn A, Kolsch BU, Fischer C, Held S, Rajewsky MF. Ethylnitrosourea-induced development of malignant schwannomas in the rat: two distinct loci on chromosome of 10 involved in tumor susceptibility and oncogenesis. Cancer Res 1999;59:1109-14.
6. Nikitin A, Ballering LA, Lyons J, Rajewsky MF. Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci U S A 1991;88:9939-43.
7. Bargmann CI, Hung MC, Weinberg RA. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986;45:649-57.
8. Perantoni AO, Rice JM, Reed CD, Watatani M, Wenk ML. Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci U S A 1987;84:6317-21.
9. Kindler-Rohrborn A, Kind AB, Koelsch BU, Fischer C, Rajewsky MF. Suppression of ethylnitrosourea-induced schwannoma development involves elimination of neu/ erbB-2 mutant premalignant cells in the resistant BDIV rat strain. Cancer Res 2000;60:4756-60.
10. Wood GA, Korkola JE, Archer MC. Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes. Carcinogenesis 2002;23:1-9.
11. 6-ethylguanine from the DNA of brain, liver, and other rat tissues exposed to ethylnitrosourea at different stages of prenatal development. Cancer Res 1983;43:2897-904.
12. Monaco S, Gehrmann J, Raivich G, Kreutzberg GW. MHC-positive, ramified macrophages in the normal and injured rat peripheral nervous system. J Neurocytol 1992;21:623-34.
13. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
14. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7.
15. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998;58:3491-4.
16. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002;3:999-1005.
17. Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970;13:1-27.
18. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
19. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.
20. Korkola JE, Wood GA, Archer MC. Resistance to chemically-induced mammary tumors in Copenhagen X nude-derived F2 athymic rats: evidence that T-cell immunity is not involved in Copenhagen resistance. Carcinogenesis 1997;18:53-7.
21. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103:481-90.
22. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
23. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-74.
24. Altenschmidt U, Kahl R, Klundt E, et al. Schwannoma cells induce a tumor-cell-specific cytotoxic-T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors. Int J Cancer 1997;70:542-50.
25. Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 1999;5:828-31.
26. Arnott CH, Scott KA, Moore RJ, et al. Tumour necrosis factor-α mediates tumour promotion via a PKC α- and AP-1-dependent pathway. Oncogene 2002;21: 4728-38.
27. Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.